ACT Medical    


Programme

Pre-Accelerate Cambridge

Sector

Healthcare/Pharma/Biotech


ACT Medical are designing a first-in-class medical device to manage haemorrhage from penetrative trauma, by applying direct internal pressure. ACT’s device will improve haemorrhage control for deep narrow junctional wounds, thus reducing haemorrhage-related mortality by a fifth, saving an estimated 288K lives a year globally. ACT’s medical device has the potential to save 300 lives per year in the UK.

Get in touch

Visit ACT Medical's website

Top